Aster DM Healthcare Limited (ASTERDM)
Outcome of Board Meeting
Q2FY27 results (unaudited):
Standalone:
Revenue 19.3bn +48% y-y (13.0bn)
PAT 0.92bn -12% y-y (1.05bn)
Six months ended 30 September 2026:
Standalone:
Revenue 20.2bn +46% y-y (13.8bn)
PAT 0.92bn -50% y-y (1.85bn)
Consolidated:
Revenue 41.4bn +77% y-y (23.4bn)
PAT 3.52bn +64% y-y (2.14bn)
Six months ended 30 September 2026:
Consolidated:
Revenue 42.3bn +81% y-y (23.4bn)
PAT 3.52bn +64% y-y (2.14bn)
Dividend: None stated
Commentary: The results include the effect of the amalgamation of Quality Care India Limited effective 1 July 2026, accounted using pooling of interests method. Non-recurring merger expenses of INR 14.23 crores and INR 124.02 crores for the quarter and six months ended 30 September 2026 respectively have been presented as exceptional items.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 ASTERDM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add ASTERDM to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Aster DM Healthcare Limited
Important.
The summary above is generated automatically from Aster DM Healthcare Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.